506 related articles for article (PubMed ID: 21091391)
1. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
[TBL] [Abstract][Full Text] [Related]
3. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
[TBL] [Abstract][Full Text] [Related]
4. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
Luthringer R; Muzet M; Zisapel N; Staner L
Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
[TBL] [Abstract][Full Text] [Related]
5. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
Dolev Z
Arch Womens Ment Health; 2011 Jun; 14(3):269-73. PubMed ID: 21311927
[TBL] [Abstract][Full Text] [Related]
6. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
Wade AG; Farmer M; Harari G; Fund N; Laudon M; Nir T; Frydman-Marom A; Zisapel N
Clin Interv Aging; 2014; 9():947-61. PubMed ID: 24971004
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.
Michelson D; Snyder E; Paradis E; Chengan-Liu M; Snavely DB; Hutzelmann J; Walsh JK; Krystal AD; Benca RM; Cohn M; Lines C; Roth T; Herring WJ
Lancet Neurol; 2014 May; 13(5):461-71. PubMed ID: 24680372
[TBL] [Abstract][Full Text] [Related]
8. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
Lemoine P; Nir T; Laudon M; Zisapel N
J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
[TBL] [Abstract][Full Text] [Related]
9. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
10. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
[TBL] [Abstract][Full Text] [Related]
12. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
[No Abstract] [Full Text] [Related]
14. Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial.
Roth T; Nir T; Zisapel N
Nat Sci Sleep; 2015; 7():13-23. PubMed ID: 25678831
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.
Lankford A; Rogowski R; Essink B; Ludington E; Heith Durrence H; Roth T
Sleep Med; 2012 Feb; 13(2):133-8. PubMed ID: 22197474
[TBL] [Abstract][Full Text] [Related]
17. Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.
Lemoine P; Garfinkel D; Laudon M; Nir T; Zisapel N
Ther Clin Risk Manag; 2011; 7():301-11. PubMed ID: 21845053
[TBL] [Abstract][Full Text] [Related]
18. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
Zisapel N
Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
